innovation hub for next generation biologics
preclinics start-up companies
BoNTANA Therapies
advanced therapeutic concepts for unique, patient-oriented neurotoxin treatments
ImmUnion
uses patients’ pre-existing tetanus immunity as a revolutionary strategy for passive and active immunization
The company
Plasmatecs
innovative approaches to develop new drugs for blood clotting disorders and inflammation using novel serine protease inhibitors
Xenodoma
the production of therapeutic proteins, cells, tissues and organs in transgenic animals is the focus of Xenodoma
For Investors
“preclinics start-up companies are working in a disciplined way to develop the medicine of tomorrow. I know my money is in good hands with you.”
For Investors
“preclinics start-up companies are working in a disciplined way to develop the medicine of tomorrow. I know my money is in good hands with you.”
For Innovators
“Hello, I am Valentina and I have been collaborating with preclinics since 2015. Now I am officially part of their innovation team and ImmUnion allows us to share our patented idea with other innovators and investors. Our team is highly motivated and passionate about bringing innovation to customers for therapeutic purposes. Click here for more information.”
For Innovators
“Hello, I am Valentina and I have been collaborating with preclinics since 2015. Now I am officially part of their innovation team and ImmUnion allows us to share our patented idea with other innovators and investors. Our team is highly motivated and passionate about bringing innovation to customers for therapeutic purposes. Click here for more information.”
ImmUnion presentation at the Rooftop Pitch Potsdam
We were proud to present our revolutionary technology platform ImmUnion at the second Rooftop Pitch Potsdam. The Rooftop Pitch Potsdam offers startup companies from different disciplines the opportunity to meet investors, business angels and other [...]
ImmUnion develops SARS-CoV-2_ImmunoJunction
ImmUnion started with the development of SARS-CoV-2 ImmunoJunction for the passive vaccination via the intranasal route. The goal is to develop a product for the use in the early stage of the disease and which [...]
ImmUnion presentation at the Rooftop Pitch Potsdam
We were proud to present our revolutionary technology platform ImmUnion at the second Rooftop Pitch Potsdam. The Rooftop Pitch Potsdam offers startup companies from different disciplines the opportunity to meet investors, business angels and other [...]
ImmUnion develops SARS-CoV-2_ImmunoJunction
ImmUnion started with the development of SARS-CoV-2 ImmunoJunction for the passive vaccination via the intranasal route. The goal is to develop a product for the use in the early stage of the disease and which [...]
ImmUnion presentation at the Rooftop Pitch Potsdam
We were proud to present our revolutionary technology platform ImmUnion at the second Rooftop Pitch Potsdam. The Rooftop Pitch Potsdam offers startup companies from different disciplines the opportunity to meet investors, business angels and other [...]
ImmUnion develops SARS-CoV-2_ImmunoJunction
ImmUnion started with the development of SARS-CoV-2 ImmunoJunction for the passive vaccination via the intranasal route. The goal is to develop a product for the use in the early stage of the disease and which [...]
Our Office
Wetzlarer Str. 20, 14482 Potsdam, Germany
